JACOB NGUYEN: Open Payments
NPI 1679249098 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 69 payments from 7 companies in 2025. Trend: 2023 $784 · 2024 $1,131 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 23 | $570 |
| Gilead Sciences, Inc. | 15 | $212 |
| Ipsen Biopharmaceuticals, Inc | 8 | $177 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $161 |
| Intercept Pharmaceuticals, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| ABBVIE INC. | 1 | $14 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, OCALIVA, MAVYRET.
Industry payments across AZ — which companies pay providers there.
